Indications for Intra-Aortic Balloon Pump (IABP) Augmentation
The intra-aortic balloon pump (IABP) is primarily indicated for specific acute mechanical complications of myocardial infarction, severe acute myocarditis, and as a bridge to more definitive therapies in selected patients, but is no longer routinely recommended for cardiogenic shock complicating acute myocardial infarction.
Primary Indications for IABP
Mechanical complications of acute myocardial infarction requiring circulatory support before surgical correction, including:
Severe acute myocarditis with hemodynamic compromise 1
Bridge therapy for patients awaiting:
Selected patients with acute myocardial ischemia or infarction before, during, and after percutaneous or surgical revascularization who are at high risk for complications 1
Not Routinely Recommended
Cardiogenic shock complicating acute myocardial infarction - The IABP-SHOCK II trial showed no mortality benefit of IABP in this setting 1
Routine use in high-risk STEMI patients - Meta-analyses of randomized trials do not support this practice 1
Other causes of cardiogenic shock not related to mechanical complications or myocarditis 1
Decision Algorithm for IABP Use
Assess for specific indications:
Evaluate hemodynamic status:
Check for contraindications:
Important Considerations
IABP insertion should be considered in patients with hemodynamic instability/cardiogenic shock due to mechanical complications of MI 1
For patients with cardiogenic shock complicating acute myocardial infarction without mechanical complications, the evidence does not support routine IABP use 1
IABP may be considered as a bridge to surgery in patients with mechanical complications of MI, particularly those with cardiogenic shock, as it significantly reduces preoperative mortality (11% vs 88%) 2
The benefit-risk ratio must be carefully evaluated, as IABP use carries risks of complications including bleeding, systemic thromboembolism, limb ischemia, and rarely death 4, 6
When used for weaning from cardiopulmonary bypass, IABP has shown a 75% success rate, with 35% of these patients surviving to hospital discharge 6
For patients with acute-on-chronic heart failure complicated by cardiogenic shock, IABP may have a physiological rationale but requires further study 3